"Rocky Mountain Diabetes Center provides comprehensive patient-focused diabetes and other endocrine care to adults and children. With our expertly trained endocrine and diabetes doctors, we provide specialized medical care, patient education and clinical research to provide relief to suffering individuals. Our healthcare providers and staff provide the very best of medical care to our patients, which includes creating a healing environment where patients are warmly received, treated with respect and dignity, and where all possible is done to lift their burdens both physically and emotionally; in other words, to establish a refuge from the storms of life where those who are ill can come to be refreshed and replenished."

During the past decade, Rocky Mountain Diabetes and Osteoporosis Center conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 35 clinical trials were completed, i.e. on average, 68.6% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 22 clinical trials were completed. i.e. 183.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rocky Mountain Diabetes and Osteoporosis Center" #1 sponsor was "Eli Lilly and Company" with 13 trials, followed by "Abbott Diabetes Care" with 10 trials sponsored, "Medtronic Diabetes" with 9 trials sponsored, "DexCom, Inc." with 7 trials sponsored and "Allergan" with 7 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rocky Mountain Diabetes and Osteoporosis Center" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator, "Medpace, Inc." with 2 trials as a collaborator, "Insulet Corporation" with 1 trials as a collaborator and "Jaeb Center for Health Research" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Rocky Mountain Diabetes and Osteoporosis Center" are "Diabetes Mellitus" (14 trials), "Type 1 Diabetes Mellitus" (14 trials), "Diabetes Mellitus, Type 2" (8 trials), "Diabetes Mellitus, Type 1" (7 trials) and "Type 2 Diabetes Mellitus" (7 trials). Many other conditions were trialed in "Rocky Mountain Diabetes and Osteoporosis Center" in a lesser frequency.

Most popular intervention types in "Rocky Mountain Diabetes and Osteoporosis Center" are "Drug" (31 trials), "Device" (29 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Insulin Glargine" (6 trials), "FreeStyle Libre Flash Glucose Monitoring System" (5 trials), "Insulin Degludec" (5 trials) and "Insulin Lispro" (5 trials). Other intervention names were less common.

The vast majority of trials in "Rocky Mountain Diabetes and Osteoporosis Center" are 65 trials for "All" genders.

Currently, there are NaN active trials in "Rocky Mountain Diabetes and Osteoporosis Center". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Rocky Mountain Diabetes and Osteoporosis Center, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Rocky Mountain Diabetes and Osteoporosis Center, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 16 trials that are defined as “Not Applicable".